Comparison of essential medicines lists in 137 countries.

Comparison of essential medicines lists in 137 countries.

<p>Objective:To compare the medicines included in national essential medicines lists with the World Health Organization's (WHO's) Model list of essential medicines, and assess the extent to which countries' characteristics, such as WHO region, size and health care expenditure,...

Description complète

Détails bibliographiques
Auteurs principaux:	Persaud, N, Jiang, M, Shaikh, R, Bali, A, Oronsaye, E, Woods, H, Drozdzal, G, Rajakulasingam, Y, Maraj, D, Wadhawan, S, Umali, N, Wang, R, McCall, M, Aronson, J, Plüddemann, A, Moja, L, Magrini, N, Heneghan, C
Format:	Journal article
Langue:	English
Publié:	World Health Organisation 2019

Documents similaires

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
par: Richards, GC, et autres
Publié: (2020)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
par: Jordan D Jarvis, et autres
Publié: (2019-01-01)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
par: Carl Heneghan, et autres
Publié: (2020-11-01)

Withdrawn medicines included in the essential medicines lists of 136 countries.
par: Onella Charles, et autres
Publié: (2019-01-01)

A comparison of national essential medicines lists in the Americas
par: Liane Steiner, et autres
Publié: (2020-01-01)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
par: Darshanand Maraj, et autres
Publié: (2022-05-01)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
par: Benedikt Huttner, et autres
Publié: (2022-02-01)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
par: Bernadette Cappello, et autres
Publié: (2020-09-01)

Integrated Diagnosis in Africa’s Low- and Middle-Income Countries: What Is It, What Works, and for Whom? A Realist Synthesis
par: Gamuchirai Gwaza, et autres
Publié: (2024-09-01)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
par: Muhamad Z. Ally, et autres
Publié: (2020-05-01)

Ten essential papers for the practice of evidence-based medicine
par: Nunan, D, et autres
Publié: (2017)

Associations between essential medicines and health outcomes for cardiovascular disease
par: Liane Steiner, et autres
Publié: (2021-03-01)

Essential cancer medicines and cancer outcomes: Cross‐sectional study of 124 countries
par: Oghenefejiro (Theresa) Ikpeni, et autres
Publié: (2023-11-01)

Święty Augustyn, List do Woluzjana (Epistula 137)
par: Andrzej P. Stefańczyk
Publié: (2010-07-01)

Biologic medicine inclusion in 138 national essential medicines lists
par: Raphaël Kraus, et autres
Publié: (2021-09-01)

A word about evidence: ‘rapid reviews’ or ‘restricted reviews’?
par: Aronson, J, et autres
Publié: (2018)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
par: Nav Persaud, et autres
Publié: (2021-08-01)

Overview of systematic reviews: yoga as a therapeutic intervention for adults with acute and chronic health conditions.
par: McCall, M, et autres
Publié: (2013)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
par: Plüddemann, A, et autres
Publié: (2018)

Tough decisions on essential medicines in 2015
par: Nicola Magrini, et autres

Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes
par: Camila Heredia, et autres
Publié: (2025-01-01)

Endocrinology and the essential list
par: Sanjay Kalra, et autres
Publié: (2012-01-01)

Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
par: Jennifer Walsh, et autres
Publié: (2022-02-01)

Characteristics and efficacy of digital health education: An overview of systematic reviews
par: McCall, M, et autres
Publié: (2018)

Transvaginal mesh failure: lessons for regulation of implantable devices.
par: Heneghan, C, et autres
Publié: (2017)

Sodium efflux and essential hypertension.
par: Boon, N, et autres
Publié: (1982)

Seasonal dynamic of content of 137Cs in mushrooms
par: N. E. Zarubina
Publié: (2007-03-01)

On Essentiality and the World Health Organization's Model List of Essential Medicines
par: Victoria A. Marks, et autres
Publié: (2017-06-01)

Catalogue of bias: novelty bias
par: Luo, Y, et autres
Publié: (2023)

Editorial No. 137
par: El Editor
Publié: (2017-02-01)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
par: Heneghan, C, et autres
Publié: (2017)

101 essential lists on assessment /
par: 464989 Rayment, Tabatha
Publié: (2006)

Evaluation of CD137 and CD137L Transcript Levels and the Serum sCD137 in Immune-mediated Polyneuropathy
par: Shirin Torkestani, et autres
Publié: (2023-03-01)

Accuracy of self-diagnosis in conditions commonly managed in primary care: diagnostic accuracy systematic review and meta-analysis
par: McLellan, JH, et autres
Publié: (2023)

Desorption of 137Cs+ from mosses
par: Dragović Snežana D., et autres
Publié: (2002-01-01)

Kinetics of 137Cs distribution in fish organism
par: V. V. Belyaev, et autres
Publié: (2006-06-01)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
par: Asma Abubakr Mustafa, et autres
Publié: (2010-12-01)

The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA.
par: McCall, M, et autres
Publié: (1986)

137Cesium (137Cs) assessment in wild boars from northwestern Italy.
par: Daniele Pattono, et autres
Publié: (2024-01-01)

137Cesium (137Cs) assessment in wild boars from northwestern Italy
par: Daniele Pattono, et autres
Publié: (2024-01-01)